Close Menu

Harvard's Pardis Sabeti -- researcher, role model, and rock star -- is profiled in this issue of Science. Sabeti has quickly become visible in her field because of a knack for hard work, raising money, and reaching out to the community, as well as being a pretty good singer. Currently, she is working on uncovering evidence of selection in the human genome in relation to susceptibility to Lassa fever.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.